ALPS
ALPS
NASDAQ · Biotechnology

Alps Group Inc

$0.93
+0.01 (+1.54%)
As of Feb 8, 2:07 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 44.46M 45.50M 43.44M
Net Income 5.47M 5.03M 5.89M
EPS
Profit Margin 12.3% 11.1% 13.6%
Rev Growth +4.4% +9.5% -0.1%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 47.60M 48.53M 40.38M
Total Equity 97.85M 101.23M 97.37M
D/E Ratio 0.49 0.48 0.41
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 8.24M 9.46M 8.95M
Free Cash Flow 4.73M 3.67M 4.46M